Insider trade

CFO sold ~$599K of G shares in the open market

Traded Nov 14, 2025 · Filed Nov 18, 2025

Why it stands out

The money chief of Genpact sold $599K of Genpact shares. It happened by itself, for taxes or pay.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

CFO$500K–$1MPre-arranged plan referenced

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$599,287

Shares × reported transaction price

Timing vs results

8 days after results of Nov 6, 2025, 83 days before results of Feb 5, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Planned / mechanical clue

Footnote references an employee stock purchase plan

Only flagged when a footnote says so; never inferred

After	Stock	S&P 500	Difference
7 days	+1.9%	+2.3%	-0.3%
30 days	+9.0%	+2.5%	+6.5%
90 days	-13.9%	+3.5%	-17.3%
180 days	-28.4%	+11.9%	-40.3%

Past results only. Not a forecast.

The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $44.81 to $44.89. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Includes 169 shares acquired under the Genpact Employee Stock Purchase Plan ("ESPP") since the reporting person's Form 4 filed on March 13, 2025. The reporting person currently holds a total of 1,358 shares under the ESPP.

Automatic sale11mo ago

11mo ago

Derivative exercise or conversion — not an open-market buy.

Officer sold11mo ago

Genpact's SVP & Chief Legal Officer sold $199K of Genpact shares. Nobody planned it ahead of time.